Professor of Vascular Surgery
The University Of New South Wales
Vascular Surgeon
Prince of Wales Hospital
Sydney, Australia
Session Moderator
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Presenter
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Presenter
SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
Presenter
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
An Update Of The 2-Year Results And Economic Cost Effectiveness Analysis Of The LIFE-BTK Randomized Controlled Comparison Of Abbott’s Esprit Drug-Eluting Resorbable Stent (DERS) With Plain Old Balloon Angioplasty (POBA): When Will DERSs Make A Difference
8:29 AM - 8:34 AM
Presenter
SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE
A Direct Comparison Of Major Contemporary EVAR Devices – Looking At Long-Term Efficacy And Patient Survival Using Big Data And Linkage Techniques
1:12 PM - 1:17 PM
Presenter
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
5-Year Results With The VBX Covered Stent For Aortoiliac Disease: Patency Rates, Advantages And Cost Effectiveness
2:42 PM - 2:47 PM
Power Point Presentation with Synched Audio
Power Point Presentation with Synched Audio